Combination of BET and FGFR inhibition as a rational therapeutic strategy for invasive lobular breast cancer

被引：0
|
作者：
O'Connor, Darran P. [1 ]
Walsh, Louise [1 ]
Haley, Kathryn [1 ]
Moran, Bruce
Mooney, Brian [1 ,2 ]
Madden, Stephen [1 ]
Das, Sudipto [1 ]
Rueda, Oscar [3 ]
Dowling, Catriona [1 ]
Vareslija, Damir [1 ]
Chin, Suet-Feung [3 ]
Linn, Sabine [4 ]
Young, Leonie [1 ]
Jirstrom, Karin [5 ]
Crown, John P. [6 ]
Bernards, Rene [4 ]
Caldas, Carlos
Gallagher, William M. [2 ]
Chonghaile, Triona Ni [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dublin, Ireland
[2] Univ Coll Dublin, Dublin, Ireland
[3] Univ Cambridge, Cambridge, England
[4] Netherlands Canc Inst, Amsterdam, Netherlands
[5] Lund Univ, Malmo, Sweden
[6] St Vincents Univ Hosp, Dublin, Ireland
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-10-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-10-06
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
    Walsh, Louise
    Haley, Kathryn E.
    Moran, Bruce
    Mooney, Brian
    Tarrant, Finbarr
    Madden, Stephen F.
    Di Grande, Alessandra
    Fan, Yue
    Das, Sudipto
    Rueda, Oscar M.
    Dowling, Catriona M.
    Vareslija, Damir
    Chin, Suet-Feung
    Linn, Sabine
    Young, Leonie S.
    Jirstrom, Karin
    Crown, John P.
    Bernards, Rene
    Caldas, Carlos
    Gallagher, William M.
    O'Connor, Darran P.
    Chonghaile, Triona Ni
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 7139 - 7150
  • [2] Rational therapeutic combination of Bromodomain and Extra-Terminal domain (BET) inhibitor and Fibroblast Growth Factor Receptor (FGFR) inhibitor for treatment of invasive lobular carcinoma
    Gao, Binbin
    Ward, Elspeth
    Blumel, Anna
    Conroy, Emer
    Moore, Rachel
    Cremin, Grainne
    Bleach, Rachel
    Haley, Kathryn
    Ni Chonghaile, Triona
    Lindner, Andreas
    Lindner, Andreas
    Prehn, Jochen
    Zhang, Yi
    Cruz, Idalia
    Hilakivi-Clarke, Leena
    Sflomos, Georgios
    Brisken, Cathrin
    Gallagher, William
    O'Connor, Darran
    CANCER RESEARCH, 2024, 84 (09)
  • [3] Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy
    Luveta, Jocelyn
    Parks, Ruth M.
    Heery, David M.
    Cheung, Kwok-Leung
    Johnston, Simon J.
    ONCOLOGY AND THERAPY, 2020, 8 (01) : 1 - 11
  • [4] Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy
    Jocelyn Luveta
    Ruth M. Parks
    David M. Heery
    Kwok-Leung Cheung
    Simon J. Johnston
    Oncology and Therapy, 2020, 8 : 1 - 11
  • [5] Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma
    Peng, Xin
    Huang, Xin
    Zhang, Shaolu
    Zhang, Naixin
    Huang, Shengfan
    Wang, Yingying
    Zhong, Zhenxing
    Zhu, Shan
    Gao, Haiwang
    Yu, Zixiang
    Yan, Xiaotong
    Tao, Zhennan
    Dai, Yuxiang
    Zhang, Zhe
    Chen, Xi
    Wang, Feng
    Claret, Francois X.
    Elkabets, Moshe
    Ji, Ning
    Zhong, Yuxu
    Kong, Dexin
    ADVANCED SCIENCE, 2024, 11 (30)
  • [6] Sequential inhibition of PARP and BET as a rational therapeutic strategy for glioblastoma multiforme
    Peng, Xin
    Huang, Xin
    Zhang, Shaolu
    Zhang, Naixin
    Huang, Shengfan
    Wang, Yingying
    Zhong, Zhenxing
    Zhu, Shan
    Gao, Haiwang
    Yu, Zixiang
    Yan, Xiaotong
    Tao, Zhennan
    Dai, Yuxiang
    Zhang, Zhe
    Chen, Xi
    Wang, Feng
    Claret, Francois X.
    Ji, Ning
    Zhong, Yuxu
    Kong, Dexin
    CANCER RESEARCH, 2024, 84 (07)
  • [7] Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
    Fu, Lei-lei
    Tian, Mao
    Li, Xiang
    Li, Jing-jing
    Huang, Jian
    Ouyang, Liang
    Zhang, Yonghui
    Liu, Bo
    ONCOTARGET, 2015, 6 (08) : 5501 - 5516
  • [8] Bromodomain and Extra-Terminal motif (BET) inhibitors are a rational therapeutic choice for treatment of invasive lobular carcinoma
    Ward, Elspeth
    Blumel, Anna
    Conroy, Emer
    Cremin, Grainne
    Gao, Binbin
    Gallagher, William
    Cruz, Idalia
    Hilakivi-Clarke, Leena
    Sflomos, George
    Brisken, Cathrin
    O'Connor, Darran
    CANCER RESEARCH, 2022, 82 (04)
  • [9] Lobular neoplasms and invasive lobular breast cancer
    Sinn, H. -P.
    Helmchen, B.
    Heil, J.
    Aulmann, S.
    PATHOLOGE, 2014, 35 (01): : 45 - 53
  • [10] Lobular carcinoma in situ and invasive lobular cancer of the breast
    Cocquyt, V
    Van Belle, S
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2005, 17 (01) : 55 - 60
12345